EMJ Oncology 10 [Supplement 5] . 2022

Journal Info

Identifying the genomic alterations in non-small cell lung cancer (NSCLC) can allow healthcare professionals to make the most suitable treatment decisions for patients. A common mutation associated with NSCLC involves mesenchymal-epithelial transition (MET). Understanding the MET mutation, and other genomic mutations associated with NSCLC, can help develop more effective personalised treatment.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?